跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
SABEXAN 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
SABEXAN 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Adventia Pharma S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 31, 2023
Approval ID
27c1d5766c577a5b
Company
Adventia Pharma S.L.
Type
Standard
Approval Details
Approval Id
27c1d5766c577a5b
Drug Cima Aemps Name
SABEXAN 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
88754
Holder Company Name
Adventia Pharma S.L.
Marketing Company Name
Atika Pharma S.L.
Authorization Date
2023-03-31
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
2,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Adventia Pharma S.L.
Active Ingredients
APIXABAN
2,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 31, 2023
Approval ID
27c1d5766c577a5b
Type
Standard
Back to CIMA-AEMPS Approvals
SABEXAN 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details